ATE386027T1 - Verfahren zur herstellung von valsartan - Google Patents

Verfahren zur herstellung von valsartan

Info

Publication number
ATE386027T1
ATE386027T1 AT04026903T AT04026903T ATE386027T1 AT E386027 T1 ATE386027 T1 AT E386027T1 AT 04026903 T AT04026903 T AT 04026903T AT 04026903 T AT04026903 T AT 04026903T AT E386027 T1 ATE386027 T1 AT E386027T1
Authority
AT
Austria
Prior art keywords
valsartan
producing valsartan
producing
preparation
novel
Prior art date
Application number
AT04026903T
Other languages
English (en)
Inventor
Giancarlo Verardo
Paola Geatti
Graziano Castaldi
Nicoletta Toniutti
Pietro Allegrini
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE386027(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Application granted granted Critical
Publication of ATE386027T1 publication Critical patent/ATE386027T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AT04026903T 2003-11-21 2004-11-12 Verfahren zur herstellung von valsartan ATE386027T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002267A ITMI20032267A1 (it) 2003-11-21 2003-11-21 Procdimento per la preparzione di valsartan e suoi intermedi

Publications (1)

Publication Number Publication Date
ATE386027T1 true ATE386027T1 (de) 2008-03-15

Family

ID=34430775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04026903T ATE386027T1 (de) 2003-11-21 2004-11-12 Verfahren zur herstellung von valsartan

Country Status (8)

Country Link
US (1) US7439261B2 (de)
EP (1) EP1533305B1 (de)
JP (1) JP2005154442A (de)
AT (1) ATE386027T1 (de)
DE (1) DE602004011730D1 (de)
ES (1) ES2300692T3 (de)
IT (1) ITMI20032267A1 (de)
PT (1) PT1533305E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0514206D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
EP1764365A1 (de) * 2005-09-20 2007-03-21 KRKA, D.D., Novo Mesto Verfahren zur Herstellung Sartanderivate und Zwischenprodukte für dieses Verfahren
ES2288376B1 (es) * 2005-10-20 2008-11-01 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
ES2316281B1 (es) * 2007-05-14 2010-02-09 Quimica Sintetica, S.A. Procedimiento para la preparacion de valsartan.
EP2316821A1 (de) 2009-10-27 2011-05-04 Novartis AG Verfahren zur Herstellung organischer Verbindungen
AR082435A1 (es) * 2010-08-03 2012-12-05 Novartis Ag Valsartan altamente cristalino
EP2902385B1 (de) * 2012-09-26 2019-01-09 API Corporation Verfahren zum entschützen einer tetrazolverbindung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000050I1 (de) * 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan

Also Published As

Publication number Publication date
ES2300692T3 (es) 2008-06-16
ITMI20032267A1 (it) 2005-05-22
US7439261B2 (en) 2008-10-21
PT1533305E (pt) 2008-04-22
JP2005154442A (ja) 2005-06-16
EP1533305A1 (de) 2005-05-25
US20050131038A1 (en) 2005-06-16
DE602004011730D1 (de) 2008-03-27
EP1533305B1 (de) 2008-02-13

Similar Documents

Publication Publication Date Title
DE502004001613D1 (de) Verfahren zur herstellung von polyamiden
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
DE60217860D1 (de) Verfahren zur herstellung von haftverschlüssen
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
DE60224643D1 (de) Verfahren zur herstellung von reifen
DE602004020476D1 (de) Verfahren zur herstellung von thermoplastischen vulkanisaten und thermoplastischen vulkanisaten
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
DE60317690D1 (de) Verfahren zur herstellung von valsartan
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
DE60333291D1 (de) Verfahren zur herstellung von flachglas
DE60304119D1 (de) Verfahren zur Herstellung von dünnwandigen gleichartigen Gitterstrukturen
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE386027T1 (de) Verfahren zur herstellung von valsartan
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
DE60314113D1 (de) Verfahren zur herstellung von phenylorganosiliciumzwischenprodukten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties